Stay updated on TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial page.

Latest updates to the TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedA new revision tag 'Revision: v3.6.6' was added and the previous tag 'Revision: v3.6.5' was removed, indicating an update to the page's version tag.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page now presents the full study record for the trial, including the overview, interventions, and outcomes, and adds the Study Protocol/Statistical Analysis Plan document. It replaces the prior error page, restoring access to essential information.SummaryDifference56%

- Check37 days agoChange DetectedRevision v3.6.5 was added to the revision history, replacing the earlier v3.6.4. This reflects a small platform update rather than a change to the trial content on the page.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, signaling a minor update to the page's template or documentation rather than substantive changes to the study information.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, indicating a new deployment/version of the page. This appears to be an internal metadata update with no visible changes to the study details or user-facing content.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a software update to the ClinicalTrials.gov page with no evident changes to the study information.SummaryDifference0.1%

Stay in the know with updates to TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial page.